Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antivirals
antivirals
Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa
Fierce Pharma
Tue, 09/27/22 - 10:27 am
Chimerix
monkeypox
Emergent BioSolutions
Tembexa
antivirals
Pardes initiates Phase II trial of Covid-19 antiviral drug
Clinical Trials Arena
Wed, 09/14/22 - 09:50 am
Pardes Biosciences
PBI-0451
COVID-19
antivirals
US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout
Fierce Pharma
Tue, 08/30/22 - 11:43 am
Chimerix
monkeypox
Tembexa
government contract
antivirals
Multiple monkeypox vaccine and antiviral trials are launching across the world
Clinical Trials Arena
Fri, 08/26/22 - 10:46 am
monkeypox
clinical trials
Bavarian Nordic
vaccines
Jynneos
SIGA technologies
TPOXX
antivirals
Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table
Endpoints
Wed, 08/10/22 - 10:44 am
monkeypox
antivirals
SIGA technologies
Chimerix
NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus
BioSpace
Thu, 08/4/22 - 11:01 am
NanoViricides
antivirals
monkeypox
drug development
Pfizer's Paxlovid sales will top at $30B this year then fall over time: analysts
Fierce Pharma
Fri, 07/22/22 - 10:13 am
Pfizer
Paxlovid
antivirals
COVID-19
Staffing shortage could be hindering controversial Paxlovid clearance
Beckers Hospital Review
Thu, 07/21/22 - 09:35 pm
Pfizer
Paxlovid
COVID-19
antivirals
FDA
pharmacists
Six months after authorization, what do we know about Paxlovid?
Pharmaforum
Fri, 06/17/22 - 10:06 am
Pfizer
COVID-19
antivirals
Paxlovid
CDC warns of rebounding symptoms after Paxlovid
Beckers Hospital Review
Thu, 05/26/22 - 10:11 am
Pfizer
Paxlovid
CDC
antivirals
COVID-19
NIH awards $577m to antiviral drug developers
Biopharma Reporter
Tue, 05/24/22 - 10:15 am
NIH
NIAID
antivirals
drug development
pandemic
Why Pfizer May Be Holding Paxlovid Close to the Chest
BioSpace
Wed, 05/18/22 - 11:54 pm
Pfizer
Paxlovid
COVID-19
antivirals
Paxlovid's post-exposure protection flop hardly spells the end for Pfizer's COVID franchise: analysts
Fierce Pharma
Mon, 05/2/22 - 11:54 am
Pfizer
Paxlovid
COVID-19
antivirals
clinical trials
How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
Stat
Thu, 04/28/22 - 10:47 am
Paxlovid
Pfizer
antivirals
COVID-19
Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid
Stat
Tue, 04/26/22 - 10:07 am
Joe Biden
antivirals
Paxlovid
Pfizer
COVID-19
Anti-Covid Pill Coming To All U.S. Pharmacies Under Reported Biden Plan
Forbes
Sat, 04/23/22 - 04:11 pm
Joe Biden
Paxlovid
COVID-19
antivirals
Could Pfizer's Paxlovid or other antivirals help cure long COVID?
Fierce Pharma
Mon, 04/18/22 - 10:46 am
Pfizer
Paxlovid
Long COVID
COVID-19
antivirals
Pfizer Signs Deal With UNICEF To Distribute Its Covid Antiviral Drug
Forbes
Tue, 03/22/22 - 10:04 am
Pfizer
antivirals
COVID-19
Paxlovid
AbbVie, eyeing shift to endemic, adds to COVID-19 work with Scripps partnership
Fierce Biotech
Tue, 03/15/22 - 11:33 pm
AbbVie
Scripps Research Institute
COVID-19
antivirals
Merck antiviral used more than expected, data shows
Beckers Hospital Review
Mon, 03/14/22 - 11:35 pm
Merck
Pfizer
antivirals
COVID-19
molnupiravir
Paxlovid
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »